INTRAUTERINE EXTRA AMNIOTIC MISOPROSTOL VERSUS VAGINAL MISOPROSTOL FOR TERMINATION OF SECOND TRIMESTER MISCARRIAGE.

dc.contributor.author	Dr. Marwa Dhafir Abd-Al-Hamid
dc.contributor.author	Dr. Sumaya Tahir Saihood
dc.contributor.author	Dr. Marwan Kamil Aboud
dc.date.accessioned	2025-12-31T15:36:27Z
dc.date.issued	2022-09-30
dc.description.abstract	The study aims to compare the efficacy and safety of two different routes of administration of misoprostol; the intrauterine extra-amniotic route and vaginal route of misoprostol in a dose of 200 microgram of misoprostol every 4 hours for the termination of pregnancy in cases of second-trimester miscarriage
dc.format	application/pdf
dc.identifier.uri	https://scholarexpress.net/index.php/wbph/article/view/1421
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/49086
dc.language.iso	eng
dc.publisher	Scholar Express Journals
dc.relation	https://scholarexpress.net/index.php/wbph/article/view/1421/1264
dc.rights	https://creativecommons.org/licenses/by-nc-nd/4.0
dc.source	World Bulletin of Public Health; Vol. 14 (2022): WBPH; 109-114
dc.source	2749-3644
dc.subject	Misoprostol
dc.subject	Miscarriage
dc.subject	Amniotic
dc.subject	Vaginal
dc.title	INTRAUTERINE EXTRA AMNIOTIC MISOPROSTOL VERSUS VAGINAL MISOPROSTOL FOR TERMINATION OF SECOND TRIMESTER MISCARRIAGE.
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: abd-al-hamid_2022_intrauterine_extra_amniotic_misoprostol.pdf
item.page.filesection.size: 174.4 KB
item.page.filesection.format: Adobe Portable Document Format